Last quarter (Q3 2023), Xeris Pharmaceuticals's total revenue was $48.32M, an increase of 62.56% from the same quarter last year. In Q3, Xeris Pharmaceuticals's net income was $-12.19M. See Xeris Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jun 23	Mar 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 114.66M	$ 38.01M	$ 33.20M	$ 110.25M	$ 49.59M	$ 20.43M
Cost of Revenue	$ 14.49M	$ 7.55M	-	$ 22.63M	$ 13.32M	$ 9.33M
Gross Profit	$ 100.17M	$ 30.45M	$ 33.20M	$ 87.61M	$ 36.27M	$ 11.11M
Operating Expense	$ 136.41M	$ 46.43M	$ 41.15M	$ 169.55M	$ 151.43M	$ 94.65M
Operating Income	$ -28.04M	$ -15.98M	$ -7.96M	$ -81.94M	$ -115.16M	$ -83.55M
Net Non Operating Interest Income Expense	$ -13.17M	$ -5.30M	$ -4.92M	$ -12.75M	$ -6.87M	$ -7.70M
Other Income Expense	$ 4.96M	$ -767.00K	$ -1.36M	$ -1.40M	$ -702.00K	$ -9.00K
Pretax Income	$ -42.63M	$ -20.52M	$ -16.83M	$ -96.08M	$ -122.72M	$ -91.25M
Tax Provision	$ -676.00K	$ -675.00K	-	$ -1.42M	$ 0.00	$ -110.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -41.95M	$ -19.84M	$ -16.83M	$ -94.66M	$ -122.72M	$ -91.14M
Basic EPS	$ -0.31	$ -0.14	$ -0.12	$ -0.70	$ -1.55	$ -2.14
Diluted EPS	$ -0.31	$ -0.14	$ -0.12	$ -0.70	$ -1.55	$ -2.14
Basic Average Shares	$ 411.19M	$ 137.34M	$ 137.14M	$ 135.63M	$ 79.03M	$ 42.64M
Diluted Average Shares	$ 411.19M	$ 137.34M	$ 137.14M	$ 135.63M	$ 79.03M	$ 42.64M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 150.90M	$ 53.99M	$ 41.15M	$ 192.19M	$ 164.75M	$ 103.98M
Net Income From Continuing And Discontinued Operation	$ -41.95M	$ -19.84M	$ -16.83M	$ -94.66M	$ -122.72M	$ -91.14M
Normalized Income	$ -31.04M	$ -21.97M	-	$ -93.28M	$ -122.02M	$ -91.13M
Interest Expense	$ 4.37M	-	-	$ 15.32M	$ 7.18M	$ 10.66M
EBIT	$ -25.20M	$ -13.99M	$ -11.92M	$ -80.76M	$ -115.55M	$ -80.59M
EBITDA	$ -12.67M	$ -7.15M	$ -9.21M	$ -68.09M	$ -113.67M	$ -79.12M

Currency in USD

Xeris Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing